CIK: 1822499 - Address: C/O Athira Pharma, Inc., 18706 North Creek Parkway, Suite 104, Bothell, WA 98011
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/5/24 19:49
9/5/24
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOChief ScS-10.56600-3-393D
2/16/24 16:32
1/5/24
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOChief ScS.a-72.910-2-380D
1/8/24 16:36
1/5/23
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOChief ScS-72.910-2-380D
3/27/23 16:57
3/24/23
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOChief ScM.d91.35061068D
10/31/22 20:17
10/28/22
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOEVP,ReseM.d51.3504661D
6/24/22 19:25
6/23/22
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOEVP,ReseS-72.690-3-458D
6/10/22 17:53
6/8/22
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOEVP,ReseM.d31.3503550D
2/18/22 19:38
2/18/22
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOEVP,ReseM.d41.1903748D
6/10/21 18:41
6/8/21
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOVP of DiM.ad31.0403844D
6/9/21 17:39
6/8/21
ATHAAthira Pharma, Inc.HealthBioPrdBiological Products, (No DiagChurch KevinWAOVP of DiM.d31.0403844D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact